Objective: This study was conducted to investigate whether polymorphisms in glycolysis-
related genes are associated with clinical outcomes of patients with advanced-stage non …

This study was conducted to investigate whether polymorphisms of genes involved in
glycolysis are associated with the prognosis of patients with non-small cell lung cancer …

We investigated the association between the clinical outcome and GSTP1 and XRCC1 gene
polymorphisms in advanced NSCLC patients with cisplatin-based chemotherapy. We …

Introduction We evaluated the role of glutathione-related genotypes on overall survival, time
to progression, adverse events, and quality of life (QOL) in stage IIIB/IV non-small cell lung …

Introduction This study is to evaluate the association of polymorphisms of glutathione S-
transferase P1 (GSTP1), copper-transporting P-type adenosine triphosphatase A (ATP7A) …

We investigated the association between the polymorphisms GSTP1 rs1695 and XRCC1
rs1799782 and rs25487 and the clinical outcome of patients with non-small cell lung cancer …

PRINCIPLES: Platinum agents cause DNA cross-linking and oxidative damage. Genetic
polymorphisms of GSTP1 and XRCC1 involved in glutathione metabolic and DNA repair …

Background: Multiple factors influence the survival of patients with lung adenocarcinoma
(LUAD). Specifically, the therapeutic outcomes of treatments and the probability of …

We conducted a study to investigate the association between the clinical outcome and
GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms …

Background Genetic polymorphisms contribute toward interindividual variations in drug
response. We investigated the effects of genetic polymorphisms on the clinical outcome of …